← Back to explorer

Servicii de Secventiere Genomica, necesare pentru efectuarea activitatilor de cercetare in cadrul poiectului de cercetare PNRR-III-C9-2023-I8, Contract de finanţare nr. 760278/26.03.2024, cu titlul "Creating a Research Group of Excellence to develop cell and immune therapy technology to target the tumor microenvironment"

TED · 365912-2026can-standardawardedNo deadline given

Buyer

NameUniversitatea de Medicina si Farmacie "Iuliu Hatieganu" Cluj-Napoca

CountryRO

Published2026-05-28

Deadline

Value

Estimated€14,377 · 75,000 RON

Awarded€12,460 · 65,000 RON

WinnerMEDLIFE

See this firm's wins →

CPV codes

73110000 Research & development services

Description

Servicii de Secventiere Genomica, necesare pentru efectuarea activitatilor de cercetare in cadrul poiectului de cercetare PNRR-III-C9-2023-I8, Contract de finanţare nr. 760278/26.03.2024, cu titlul "Creating a Research Group of Excellence to develop cell and immune therapy technology to target the tumor microenvironment" - director proiect prof. dr. Hermann Einsele – sunt detaliate in caietul de sarcini.

Similar tenders

Closest by meaning — across languages, via embeddings.

PublishedTitleBuyerMatch
2026-06-24Reactivi si materiale consumabile -3 loturi, necesare pentru efectuarea activitatilor de cercetare in cadrul proiectului : PNRR Contract de finanţare nr. 760280/26.03.2024, CF 199/31.07.2023, cu titlul " Deciphering the Genetic and Genomic Architecture of Systemic Lupus ErythematosusUniversitatea de Medicina si Farmacie "Iuliu Hatieganu" Cluj-Napoca RO92%
2026-06-24Servicii de Secvențierea ARN-ului unicelular din PBMC-uri umane (celule mononucleare din sângele periferic) derivate din probe de sange uman -30 de probe de cancer tiroidianUniversitatea de Medicina si Farmacie "Iuliu Hatieganu" Cluj-Napoca RO91%
2026-06-22“Reactivi si consumabile - 3 loturi, necesare pentru efectuarea activitatilor de cercetare in cadrul proiectului de cercetare Contract de finanţare nr. 760064/23.05.2023, CF 36/14.11.2022, cu titlul " Translational research targeting fibrosis regression, endothelial dysfunction reversal and hepatocytes regeneration in advanced liver diseases – 3RE-VALID”Universitatea de Medicina si Farmacie "Iuliu Hatieganu" Cluj-Napoca RO90%
2026-05-15Cititor multimodal de microplaci si Sistem de detectie PCR in timp real (RT-PCR), necesare pentru efectuarea activitatilor de cercetare in cadrul poiectului de cercetare PNRR 760066/23.05.2023, CF 83/15.11.2022, cu titlul "LUNG SQUAMOUS CELL CARCINOMA THERAPEUTIC TARGETS USING SYSTEMS-LEVEL MACHINE LEARNING BASED ON SINGLE-CELL RNA-SEQUENCING"Universitatea de Medicina si Farmacie "Iuliu Hatieganu" Cluj-Napoca RO90%
2026-05-08Reactivi si consumabile - 2 loturi necesare pentru efectuarea activitatilor de cercetare in cadrul proiectului de cercetare PNRR, "SysScleRO – Systems immunology for systemic sclerosis (SSc): assessment of innate immune memory and immune aging as basis for individualised prevention and treatment modalities in SSc" CF 82/31.07.2023, Contract de finanțare nr.760236/28.12.2023Universitatea de Medicina si Farmacie "Iuliu Hatieganu" Cluj-Napoca RO89%
2026-05-15Acord cadru – Reactivi si consumabile de laborator – 12 loturi in cadrul proiectului PNRR "SysScleRO – Systems immunology for systemic sclerosis (SSc): assessment of innate immune memory and immune aging as basis for individualised prevention and treatment modalities in SSc" CF 82/31.07.2023, Contract de finanțare nr.760236/28.12.2023Universitatea de Medicina si Farmacie "Iuliu Hatieganu" Cluj-Napoca RO89%

Source

View the official notice on TED